Terms: = Gastric cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK
1040 results:
1. EGFR and PI3K Signalling Pathways as Promising Targets on Circulating Tumour Cells from Patients with Metastatic gastric Adenocarcinoma.
Piper AK; Penney C; Holliday J; Tincknell G; Ma Y; Napaki S; Pantel K; Brungs D; Ranson M
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791602
[TBL] [Abstract] [Full Text] [Related]
2. ECHDC2 inhibits the proliferation of gastric cancer cells by binding with NEDD4 to degrade MCCC2 and reduce aerobic glycolysis.
He J; Yi J; Ji L; Dai L; Chen Y; Xue W
Mol Med; 2024 May; 30(1):69. PubMed ID: 38783226
[TBL] [Abstract] [Full Text] [Related]
3. Modified Banxiaxiexin decoction benefitted chemotherapy in treating gastric cancer by regulating multiple targets and pathways.
Zhang Z; Wu C; Liu N; Wang Z; Pan Z; Jiang Y; Tian J; Sun M
J Ethnopharmacol; 2024 Sep; 331():118277. PubMed ID: 38697407
[TBL] [Abstract] [Full Text] [Related]
4. Cold-shock Domain Protein A (CSDA) Influences Hepatocyte Growth Factor-medicated Cell Proliferation and Metastasis in gastric cancer Cells.
Jung JY; Koh SA; Lee KH
Anticancer Res; 2024 May; 44(5):1973-1981. PubMed ID: 38677740
[TBL] [Abstract] [Full Text] [Related]
5. A Phase I Study of KIN-3248, an Irreversible Small-molecule Pan-FGFR Inhibitor, in Patients with Advanced FGFR2/3-driven Solid Tumors.
Garmezy B; Borad MJ; Bahleda R; Perez CA; Chen LT; Kato S; Oh DY; Severson P; Tam BY; Quah CS; Harding JJ
Cancer Res Commun; 2024 Apr; 4(4):1165-1173. PubMed ID: 38602417
[TBL] [Abstract] [Full Text] [Related]
6. Role of ONECUT family transcription factors in cancer and other diseases.
Sunita Prajapati K; Gupta S; Chaudhri S; Kumar S
Exp Cell Res; 2024 May; 438(1):114035. PubMed ID: 38593917
[TBL] [Abstract] [Full Text] [Related]
7. A Natural Peptide from A Traditional Chinese Medicine Has the Potential to Treat Chronic Atrophic Gastritis by Activating gastric Stem Cells.
Li K; Ma X; Li Z; Liu Y; Shen G; Luo Z; Wang D; Xia L; Wang Z; Tian M; Liu H; Geng F; Li B
Adv Sci (Weinh); 2024 May; 11(20):e2304326. PubMed ID: 38544338
[TBL] [Abstract] [Full Text] [Related]
8. USP50 regulates NLRP3 inflammasome activation in duodenogastric reflux-induced gastric tumorigenesis.
Zhao C; Mu M; Li X; Dong Z; Wang J; Yao C; Zheng J; Sun X; Yu J
Front Immunol; 2024; 15():1326137. PubMed ID: 38469295
[TBL] [Abstract] [Full Text] [Related]
9. Xianglian Pill combined with 5-fluorouracil enhances antitumor activity and reduces gastrointestinal toxicity in gastric cancer by regulating the p38 MAPK/NF-ÎșB signaling pathway.
Yu L; Qin JY; Sun C; Peng F; Chen Y; Wang SJ; Tang J; Lin ZW; Wu LJ; Li J; Cao XY; Li WQ; Xie XF; Peng C
J Ethnopharmacol; 2024 May; 326():117988. PubMed ID: 38428657
[TBL] [Abstract] [Full Text] [Related]
10. RAE1 promotes gastric carcinogenesis and epithelial-mesenchymal transition.
Dong W; Li X; Cheng L; Yang J; Zhao Z; Qiang X; Li P; Wu J; Guo L
Arch Biochem Biophys; 2024 Apr; 754():109896. PubMed ID: 38417691
[TBL] [Abstract] [Full Text] [Related]
11. Anticancer Effects of
Han EJ; Choi EY; Jeon SJ; Moon JM; Lee SW; Lee JH; Jung GH; Han SH; Jung SH; Yang MS; Jung JY
J Med Food; 2024 Apr; 27(4):330-338. PubMed ID: 38387002
[TBL] [Abstract] [Full Text] [Related]
12. Killer cell lectin-like receptor G2 facilitates aggressive phenotypes of gastric cancer cells via dual activation of the erk1/2 and JAK/STAT pathways.
Ito Y; Kanda M; Sasahara M; Tanaka C; Shimizu D; Umeda S; Inokawa Y; Hattori N; Hayashi M; Nakayama G; Kodera Y
Gastric Cancer; 2024 May; 27(3):506-518. PubMed ID: 38386237
[TBL] [Abstract] [Full Text] [Related]
13. Helicobacter pylori CagA-mediated ether lipid biosynthesis promotes ferroptosis susceptibility in gastric cancer.
Peng Y; Lei X; Yang Q; Zhang G; He S; Wang M; Ling R; Zheng B; He J; Chen X; Li F; Zhou Q; Zhao L; Ye G; Li G
Exp Mol Med; 2024 Feb; 56(2):441-452. PubMed ID: 38383581
[TBL] [Abstract] [Full Text] [Related]
14. Homeobox Protein BarH-like 1 Promotes gastric cancer Progression by Activating Coiled-Coil Domain-Containing Protein 178.
Gu Y; Chen G; Ning X
Dig Dis Sci; 2024 Apr; 69(4):1182-1199. PubMed ID: 38358459
[TBL] [Abstract] [Full Text] [Related]
15. Epigenetic disruption of histone deacetylase-2 accelerated apoptotic signaling and retarded malignancy in gastric cells.
Hosseini SA; Ghatrehsamani M; Yaghoobi H; Elahian F; Mirzaei SA
Epigenomics; 2024 Mar; 16(5):277-292. PubMed ID: 38356395
[TBL] [Abstract] [Full Text] [Related]
16. Impacts of hyperthermic chemotherapeutic agent on cytotoxicity, chemoresistance-related proteins and PD-L1 expression in human gastric cancer cells.
Su BC; Chen GY; Yang CM; Chuang WT; Lin MC; Hsu PL; Lee CW; Cheng CC; Wu SY; Pan BS; Yu HH
Int J Hyperthermia; 2024; 41(1):2310017. PubMed ID: 38350654
[No Abstract] [Full Text] [Related]
17. Jaceosidin induces apoptosis and inhibits migration in AGS gastric cancer cells by regulating ROS-mediated signaling pathways.
Liu J; Li SM; Tang YJ; Cao JL; Hou WS; Wang AQ; Wang C; Jin CH
Redox Rep; 2024 Dec; 29(1):2313366. PubMed ID: 38318818
[TBL] [Abstract] [Full Text] [Related]
18. Transcription factor E2F7 activates PKMYT1 to partially suppress adriamycin sensitivity in gastric cancer through the MAPK signaling pathway.
Yang X; Zeng J; Jiang C; Zhang Y; Zhang X
Rev Invest Clin; 2024 Mar; 76(1):6-17. PubMed ID: 38253021
[TBL] [Abstract] [Full Text] [Related]
19. Macrophages reprogramming improves immunotherapy of IL-33 in peritoneal metastasis of gastric cancer.
Che K; Luo Y; Song X; Yang Z; Wang H; Shi T; Wang Y; Wang X; Wu H; Yu L; Liu B; Wei J
EMBO Mol Med; 2024 Feb; 16(2):251-266. PubMed ID: 38238529
[TBL] [Abstract] [Full Text] [Related]
20. Medicine for chronic atrophic gastritis: a systematic review, meta- and network pharmacology analysis.
Weng J; Wu XF; Shao P; Liu XP; Wang CX
Ann Med; 2023; 55(2):2299352. PubMed ID: 38170849
[TBL] [Abstract] [Full Text] [Related]
[Next]
